10 20 30 40 50 60 70 80 2DX4 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER DE NOVO PROTEIN 23-AUG-06 2DX4
TITLE NMR STRUCTURE OF DP5_CONFORMATION2: MONOMERIC BETA-HAIRPIN
COMPND MOL_ID: 1; COMPND 2 MOLECULE: DP5_CONFORMATION2; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED AND SOURCE 4 DOES NOT APPEAR TO OCCUR IN NATURE. THIS SEQUENCE WAS SOURCE 5 DESIGNED BASED ON A STRATEGY.
KEYWDS BETA-HAIRPIN, DE NOVO PROTEIN
EXPDTA SOLUTION NMR
NUMMDL 10
AUTHOR A.TAMURA,M.ARAKI
REVDAT 3 24-FEB-09 2DX4 1 VERSN REVDAT 2 27-FEB-07 2DX4 1 JRNL REVDAT 1 02-JAN-07 2DX4 0
JRNL AUTH M.ARAKI,A.TAMURA JRNL TITL TRANSFORMATION OF AN ALPHA-HELIX PEPTIDE INTO A JRNL TITL 2 BETA-HAIRPIN INDUCED BY ADDITION OF A FRAGMENT JRNL TITL 3 RESULTS IN CREATION OF A COEXISTING STATE. JRNL REF PROTEINS V. 66 860 2006 JRNL REFN ISSN 0887-3585 JRNL PMID 17177204 JRNL DOI 10.1002/PROT.21263
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DYANA 1.5 REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2DX4 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-AUG-06. REMARK 100 THE RCSB ID CODE IS RCSB025951.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283 REMARK 210 PH : 4.5 REMARK 210 IONIC STRENGTH : 6.5MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1MM TP; 10MM ACETIC ACID-3MM REMARK 210 NAOH BUFFER, 90% H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY, 2D TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ REMARK 210 SPECTROMETER MODEL : DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : DYANA 1.5, NMRPIPE 1.7, REMARK 210 XWINNMR 1.3 REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURES WERE DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 2 66.01 80.00 REMARK 500 1 TRP A 4 -86.97 -70.43 REMARK 500 1 ALA A 6 106.38 -39.22 REMARK 500 1 HIS A 7 -60.50 -152.80 REMARK 500 1 ALA A 8 -100.29 -176.84 REMARK 500 1 LYS A 9 52.57 33.67 REMARK 500 1 ALA A 10 58.05 72.28 REMARK 500 1 VAL A 14 -154.61 -128.22 REMARK 500 1 HIS A 15 56.45 -164.15 REMARK 500 1 TRP A 16 -160.40 -72.95 REMARK 500 1 THR A 17 131.63 171.01 REMARK 500 2 TYR A 3 77.33 -107.95 REMARK 500 2 TRP A 4 -77.04 -41.04 REMARK 500 2 ALA A 6 98.07 -38.64 REMARK 500 2 ALA A 8 -92.23 -42.57 REMARK 500 2 LYS A 9 49.19 35.79 REMARK 500 2 ALA A 10 53.85 70.15 REMARK 500 2 ILE A 13 100.31 -40.48 REMARK 500 2 VAL A 14 -168.27 -117.59 REMARK 500 2 HIS A 15 58.13 -161.82 REMARK 500 2 TRP A 16 -159.56 -68.91 REMARK 500 3 ASN A 2 141.85 165.83 REMARK 500 3 TYR A 3 24.91 -156.75 REMARK 500 3 LEU A 5 -94.79 66.70 REMARK 500 3 ALA A 6 48.54 85.24 REMARK 500 3 ALA A 8 -96.73 -49.53 REMARK 500 3 HIS A 15 56.72 -155.46 REMARK 500 3 TRP A 16 -160.47 -77.93 REMARK 500 4 LEU A 5 -109.54 64.19 REMARK 500 4 ALA A 6 91.96 83.58 REMARK 500 4 HIS A 7 -63.46 -155.36 REMARK 500 4 ALA A 8 -99.88 -178.27 REMARK 500 4 LYS A 9 53.50 34.14 REMARK 500 4 ALA A 10 56.84 73.15 REMARK 500 4 VAL A 14 -158.81 -132.08 REMARK 500 4 HIS A 15 52.75 -162.75 REMARK 500 4 TRP A 16 -159.19 -77.77 REMARK 500 5 ASN A 2 73.78 -111.73 REMARK 500 5 TYR A 3 37.70 -88.73 REMARK 500 5 TRP A 4 -78.96 -48.13 REMARK 500 5 ALA A 6 106.53 -39.28 REMARK 500 5 HIS A 7 -62.01 -155.86 REMARK 500 5 ALA A 8 -105.11 -178.05 REMARK 500 5 LYS A 9 50.41 35.21 REMARK 500 5 ALA A 10 56.79 83.27 REMARK 500 5 VAL A 14 -160.23 -102.10 REMARK 500 5 HIS A 15 56.98 -164.94 REMARK 500 5 TRP A 16 -160.31 -73.64 REMARK 500 6 ASN A 2 92.10 160.39 REMARK 500 6 TYR A 3 49.77 -86.75 REMARK 500 6 ALA A 6 91.97 -52.09 REMARK 500 6 HIS A 7 -70.07 -132.57 REMARK 500 6 ALA A 8 -111.12 174.92 REMARK 500 6 LYS A 9 70.31 40.29 REMARK 500 6 ALA A 10 61.07 60.45 REMARK 500 6 VAL A 14 -169.16 -120.41 REMARK 500 6 HIS A 15 47.25 -140.90 REMARK 500 6 TRP A 16 -170.96 -67.51 REMARK 500 7 ASN A 2 91.26 -67.63 REMARK 500 7 TYR A 3 49.87 -97.09 REMARK 500 7 TRP A 4 -80.60 -44.30 REMARK 500 7 LEU A 5 23.04 43.72 REMARK 500 7 ALA A 6 104.79 -48.02 REMARK 500 7 ALA A 8 -93.62 -40.10 REMARK 500 7 LYS A 9 50.52 32.87 REMARK 500 7 ILE A 13 98.87 -41.82 REMARK 500 7 VAL A 14 -160.37 -125.87 REMARK 500 7 HIS A 15 61.60 -164.47 REMARK 500 7 TRP A 16 -160.67 -74.34 REMARK 500 8 TRP A 4 -80.87 -45.15 REMARK 500 8 ALA A 6 92.67 -46.22 REMARK 500 8 ALA A 8 -163.83 -64.01 REMARK 500 8 LYS A 9 85.10 86.30 REMARK 500 8 VAL A 14 -156.89 -120.99 REMARK 500 8 HIS A 15 53.30 -173.45 REMARK 500 8 TRP A 16 -160.90 -60.17 REMARK 500 8 THR A 17 21.20 -154.00 REMARK 500 9 TYR A 3 56.85 -99.55 REMARK 500 9 TRP A 4 -76.49 -42.95 REMARK 500 9 ALA A 6 104.68 -37.97 REMARK 500 9 HIS A 7 -61.42 -153.83 REMARK 500 9 ALA A 8 -85.16 -176.75 REMARK 500 9 LYS A 9 46.04 39.77 REMARK 500 9 ALA A 10 -46.30 86.77 REMARK 500 9 ILE A 13 104.44 -51.23 REMARK 500 9 VAL A 14 -159.86 -121.79 REMARK 500 9 HIS A 15 58.04 -161.02 REMARK 500 9 TRP A 16 -160.35 -78.76 REMARK 500 10 ASN A 2 68.68 61.30 REMARK 500 10 TRP A 4 -79.35 -40.77 REMARK 500 10 LEU A 5 85.49 36.27 REMARK 500 10 HIS A 7 -58.71 -146.62 REMARK 500 10 ALA A 8 -86.51 -177.54 REMARK 500 10 LYS A 9 53.19 28.48 REMARK 500 10 ALA A 10 40.98 86.31 REMARK 500 10 VAL A 14 -158.60 -145.28 REMARK 500 10 HIS A 15 54.69 -165.45 REMARK 500 10 TRP A 16 -161.07 -72.06 REMARK 500 REMARK 500 REMARK: NULL
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2DX2 RELATED DB: PDB REMARK 900 TARGET PEPTIDE REMARK 900 RELATED ID: 2DX3 RELATED DB: PDB REMARK 900 DP5_CONFORMATION1
DBREF 2DX4 A 1 18 PDB 2DX4 2DX4 1 18
SEQRES 1 A 18 ILE ASN TYR TRP LEU ALA HIS ALA LYS ALA GLY TYR ILE SEQRES 2 A 18 VAL HIS TRP THR ALA
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000